Cargando…
Preclinical evaluation of local prolonged release of paclitaxel from gelatin microspheres for the prevention of recurrence of peritoneal carcinomatosis in advanced ovarian cancer
Patients with advanced ovarian cancer develop recurrence despite initial treatment response to standard treatment of surgery and intravenous/intraperitoneal (IP) chemotherapy, partly due to a limited peritoneal exposure time of chemotherapeutics. Paclitaxel-loaded genipin-crosslinked gelatin microsp...
Autores principales: | De Clercq, Kaat, Xie, Feifan, De Wever, Olivier, Descamps, Benedicte, Hoorens, Anne, Vermeulen, An, Ceelen, Wim, Vervaet, Chris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6795903/ https://www.ncbi.nlm.nih.gov/pubmed/31619730 http://dx.doi.org/10.1038/s41598-019-51419-y |
Ejemplares similares
-
Pretreatment with VEGF(R)-inhibitors reduces interstitial fluid pressure, increases intraperitoneal chemotherapy drug penetration, and impedes tumor growth in a mouse colorectal carcinomatosis model
por: Gremonprez, Félix, et al.
Publicado: (2015) -
Intraperitoneal aerosolization of albumin-stabilized paclitaxel nanoparticles (Abraxane™) for peritoneal carcinomatosis – a phase I first-in-human study
por: Van De Sande, Leen, et al.
Publicado: (2018) -
Pharmacological effects of 5-fluorouracil microspheres on peritoneal carcinomatosis in animals.
por: Hagiwara, A., et al.
Publicado: (1996) -
Phase I study of intraperitoneal aerosolized nanoparticle albumin based paclitaxel (NAB-PTX) for unresectable peritoneal metastases
por: Ceelen, Wim, et al.
Publicado: (2022) -
Aerosolization of Nanotherapeutics as a Newly Emerging Treatment Regimen for Peritoneal Carcinomatosis
por: Shariati, Molood, et al.
Publicado: (2019)